1. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes
   Pierre-Adrien Bolze et al, 2017, International Journal of Gynecological Cancer CrossRef
2. Targeting the Pd-1 Pathway in Renal Cell Carcinoma: A Review
   Lisa Derosa et al, 2017, Journal of Onco-Nephrology CrossRef
3. Occurrence–regression–recurrence of hepatocellular carcinoma without any intervention: A case report
   Weinan Li et al, 2022, Frontiers in Surgery CrossRef
4. Role of Surgery in Metastatic Renal Cell Carcinoma
   José Ignacio Nolazco et al, 2023, Hematology/Oncology Clinics of North America CrossRef
5. A case of metastatic renal cell carcinoma showing complete remission after cytoreductive nephrectomy followed by temsirolimus
   Naotaka Nishiyama et al, 2017, International Cancer Conference Journal CrossRef
6. Prognostic indicators of pulmonary metastasis in patients with renal cell carcinoma who have undergone radical nephrectomy
   Ja Ku et al, 2019, Oncology Letters CrossRef
7. Transition to Targeted Therapies Improved the Prognosis and Increased the Utilization of Medical Treatments among Patients with Synchronous Metastatic Renal Cell Cancer
   Lauri Laru et al, 2021, International Journal of Surgical Oncology CrossRef
8. Efficacy of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography for detecting renal cell carcinoma in patients with end-stage renal disease
   Hiromi Hirasawa et al, 2024, Japanese Journal of Radiology CrossRef
9. PD-1 Blockade in Renal Cell Carcinoma
   Lisa Derosa et al, 2018, Oncoimmunology CrossRef